Futura Medical PLC
21 June 2006
For immediate release 21 June 2006
Futura Medical plc
Futura Medical plc (AIM: FUM), the pharmaceutical drug and medical device group
that develops innovative products for sexual health, confirms that, further to
recent press speculation, it has been advised by the major pharmaceutical group
that the formal approval process is in its final stage, as announced on 9 May
2006. The Company is also exploring the possibility of undertaking a small cash
placing and is in consultation with its advisors but no decision has yet been
taken. Shareholders will be kept informed of all material developments.
For further information:
Futura Medical plc
James Barder, Chief Executive Tel: +44 (0) 1483 845 670
mail to: james.barder@futuramedical.co.uk www.futuramedical.co.uk
Media enquiries:
Buchanan Communications
Mark Court/Rebecca Skye Dietrich/Camilla Simpson Tel: +44 (0) 20 7466 5000
This information is provided by RNS
The company news service from the London Stock Exchange
*A Private Investor is a recipient of the information who meets all of the conditions set out below, the recipient:
Obtains access to the information in a personal capacity;
Is not required to be regulated or supervised by a body concerned with the regulation or supervision of investment or financial services;
Is not currently registered or qualified as a professional securities trader or investment adviser with any national or state exchange, regulatory authority, professional association or recognised professional body;
Does not currently act in any capacity as an investment adviser, whether or not they have at some time been qualified to do so;
Uses the information solely in relation to the management of their personal funds and not as a trader to the public or for the investment of corporate funds;
Does not distribute, republish or otherwise provide any information or derived works to any third party in any manner or use or process information or derived works for any commercial purposes.
Please note, this site uses cookies. Some of the cookies are essential for parts of the site to operate and have already been set. You may delete and block all cookies from this site, but if you do, parts of the site may not work. To find out more about the cookies used on Investegate and how you can manage them, see our Privacy and Cookie Policy
To continue using Investegate, please confirm that you are a private investor as well as agreeing to our Privacy and Cookie Policy & Terms.